In their study, they investigated the expression of STAT3 and STAT5 in more than 500 BC tissues by immunohistochemical techniques and observed that in ER+ patients with STAT5 positive tumors there was significantly increased overall survival, thereby suggesting that expression of STAT5 is helpful in selecting patients who could possibly benefit from endocrine therapy (336). The gene discussed is STAT3; the disease is breast cancer.